
Sign up to save your podcasts
Or


Back in October 1998, we published the first version of the Cochrane review of the effects of cranberry for preventing urinary tract infections. Twenty-five years on, the sixth update was published in November 2023 and here's lead author, Gabrielle Williams from University of Sydney in Australia to bring us up to date in this podcast.
Alongside the several Cochrane reviews of ways to prevent falls in older people, a new review of the effects of cognitive behavioural therapy on their fear of falling was added in November 2023. Here's lead author, Eric Lenouvel from the University Hospital of Psychiatry in Bern Switzerland, to tell us more.
The Cochrane Skin Group has produced some of the largest Cochrane reviews, providing a “one stop shop” for people interested in a wide range of interventions for a particular skin condition. One such example is the review of systemic medicines to treat psoriasis, which was updated for the fourth time in July 2023. We asked two of the authors, Laurence Le Cleach, head of the French satellite of the Cochrane Skin group, and dermatologist at Henri Mondor hospital, AP-HP in France and Emilie Sbidian, a dermatologist working at the same hospital, to describe the findings. Here's Laurence to begin.
Age-related macular degeneration is a progressive and sight-threatening disease affecting the central area of the retina at the back of the eye. There are Cochrane Reviews of the use of antioxidant vitamin and mineral supplements to prevent or slow down progression of the disease and the latter was updated in September 2023. Here's lead author, Jenny Evans from the London School of Hygiene and Tropical Medicine in the UK to tell us about the latest evidence.
Hypertrophic and keloid scars are common skin conditions resulting from abnormal wound healing. One possible treatment involves the use of a laser and a new Cochrane Review of the evidence was published in September 2022. We asked one of the authors, Ana Carolina Nunes from Cochrane Brazil in Sao Paolo, to tell us more in this podcast.
The many Cochrane Reviews related to the use of insulin for people with diabetes were added to in November 2023 with a new review of the thermal stability and storage of human insulin. Here's Bernd Richter, lead author and Emeritus Coordinating Editor of the Cochrane Metabolic and Endocrine Disorders Group, based in Düsseldorf, Germany, to tell us what they found.
An important problem for babies who are born too early is a condition called apnea and a new Cochrane review published in October 2023 brings together the evidence on the effects of a class of drugs called methylxanthines. We asked one of the authors, Matteo Bruschettini from Cochrane Sweden, to tell us about the review's findings in this podcast and he used an AI voice from elevenlabs.io to make the recording.
The many Cochrane Reviews related to the use of insulin for people with diabetes were added to in November 2023 with a new review of the thermal stability and storage of human insulin. Here's Bernd Richter, lead author and Emeritus Coordinating Editor of the Cochrane Metabolic and Endocrine Disorders Group, based in Düsseldorf, Germany, to tell us what they found.
Cochrane Work has produced many systematic reviews of interventions that might help workers stay safe in the workplace. In this podcast, Roos Schelvis, senior researcher in mental health and work and Sietske Tamminga, assistant professor, both from Amsterdam University Medical Center in the Netherlands discuss the May 2023 update of one of these, which looks at the effects of individual-level stress interventions for healthcare workers.
Clear communication with the public is a key part of the response to disasters and health emergencies, and the October 2023 update of a rapid review from 2020 investigates this in relation to measures to help to prevent and control COVID-19. Here's lead author Rebecca Ryan from La Trobe University in Australia to tell us more.
From the publisher's feed